Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gabriel E. Troche
Observed name:
Gabriel Troche
Observed institution:
Pfizer (United States)
ORCID:
0000-0003-4466-0732
Observed ORCID:
0000-0003-4466-0732
OpenAlex ID:
A5080034026
Noninvasive Saliva-based EGFR Gene Mutation Detection in Patients with Lung Cancer
2014
·
Fang Wei
, Chien-Chung Lin
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
182
Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy
2008
·
Cathy Zhang
, Karen Lundgren
, et al.
·
Molecular Cancer Therapeutics
·
12
Epithelial Tissue Hyperplasia Induced by the RAF Inhibitor PF-04880594 Is Attenuated by a Clinically Well-Tolerated Dose of the MEK Inhibitor PD-0325901
2012
·
Vince R. Torti
, Donald Wojciechowicz
, et al.
·
Molecular Cancer Therapeutics
·
9
AG-024322 is a multi-targeted CDK inhibitor with potent antitumor activity in vivo
2005
·
Cathy C. Zhang
, Gabriel E. Troche
, et al.
·
Cancer Research
·
9
Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2023
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
·
Molecular Cancer Therapeutics
·
4
PDF
Supplementary Figure S3 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S6 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Table S1 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S1 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S2 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S5 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Table S2 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S7 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S4 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Methods from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2025
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Table S1 from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S6 from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S1 from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S2 from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S7 from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Table S2 from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S4 from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Data from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Figure S5 from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Supplementary Methods from Efficacy and Imaging Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
2024
·
Catherine Lee
, Ziyue Karen Jiang
, et al.
Show more works
View as search
Works count:
56
Citation count:
216
H-index:
4
I10-index:
2
Year
Topic
Type